Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales: Novy, Emmanuel, Scala-Bertola, Julien, Roger, Claire, Guerci, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166006/
https://www.ncbi.nlm.nih.gov/pubmed/32315803
http://dx.doi.org/10.1016/j.accpm.2020.04.005
_version_ 1783523484411887616
author Novy, Emmanuel
Scala-Bertola, Julien
Roger, Claire
Guerci, Philippe
author_facet Novy, Emmanuel
Scala-Bertola, Julien
Roger, Claire
Guerci, Philippe
author_sort Novy, Emmanuel
collection PubMed
description
format Online
Article
Text
id pubmed-7166006
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-71660062020-04-20 Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection Novy, Emmanuel Scala-Bertola, Julien Roger, Claire Guerci, Philippe Anaesth Crit Care Pain Med Letter to the Editor Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2020-06 2020-04-18 /pmc/articles/PMC7166006/ /pubmed/32315803 http://dx.doi.org/10.1016/j.accpm.2020.04.005 Text en © 2020 Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Novy, Emmanuel
Scala-Bertola, Julien
Roger, Claire
Guerci, Philippe
Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection
title Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection
title_full Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection
title_fullStr Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection
title_full_unstemmed Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection
title_short Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection
title_sort preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with sars-cov-2 infection
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166006/
https://www.ncbi.nlm.nih.gov/pubmed/32315803
http://dx.doi.org/10.1016/j.accpm.2020.04.005
work_keys_str_mv AT novyemmanuel preliminarytherapeuticdrugmonitoringdataofblactamsincriticallyillpatientswithsarscov2infection
AT scalabertolajulien preliminarytherapeuticdrugmonitoringdataofblactamsincriticallyillpatientswithsarscov2infection
AT rogerclaire preliminarytherapeuticdrugmonitoringdataofblactamsincriticallyillpatientswithsarscov2infection
AT guerciphilippe preliminarytherapeuticdrugmonitoringdataofblactamsincriticallyillpatientswithsarscov2infection

Ejemplares similares